{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:27:44Z","timestamp":1783733264488,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"Singapore National Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.mrrev.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T16:16:29Z","timestamp":1539792989000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson\u2019s disease (PD)"],"prefix":"10.1016","volume":"778","author":[{"given":"Zhi Dong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Chao Tristan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2018.10.001_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.14253","article-title":"Mechanistic contributions of FBXO7 to Parkinson disease","volume":"144","author":"Joseph","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0015","first-page":"1","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","article-title":"Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson\u2019s disease","volume":"157","author":"Martin","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/2007-00100.Irvine","article-title":"Protein aggregation in the brain: the molecular basis for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Irvine","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1172\/JCI38619","article-title":"Protein degradation in Parkinson disease revisited: it\u2019s complex","volume":"119","author":"Li","year":"2009","journal-title":"J Clin. Invest."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson\u2019s disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson\u2019s disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"issue":"June","key":"10.1016\/j.mrrev.2018.10.001_bib0060","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (80-)"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15500","article-title":"Loss of Parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c","volume":"8","author":"Meng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0070","first-page":"1","article-title":"Association of the COQ2 V393A variant with Parkinson\u2019s disease: a case-control study and meta-analysis","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0075","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/humu.20507","article-title":"Pathogenic mutations in Parkinson disease","volume":"28","author":"Tan","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive Parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and Spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130131","article-title":"Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins","volume":"3","author":"Nelson","year":"2013","journal-title":"Open Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Di Fonzo","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1389203717666160311121433","article-title":"Structure and function of Fbxo7\/PARK15 in Parkinson\u2019s disease","volume":"18","author":"Randle","year":"2018","journal-title":"Curr. Protein Peptide Sci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science (80-)"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2000-1-5-reviews3002","article-title":"The F-box protein family","volume":"1","author":"Kipreos","year":"2000","journal-title":"Genome Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1534\/genetics.109.105726","article-title":"mec-15 encodes an F-box protein required for touch receptor neuron mechanosensation, synapse formation and development","volume":"183","author":"Bounoutas","year":"2009","journal-title":"Genetics"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0125","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1073\/pnas.0736949100","article-title":"Circadian phase-specific degradation of the F-box protein ZTL is mediated by the proteasome","volume":"100","author":"Kim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrm3582","article-title":"Mechanisms and function of substrate recruitment by F-box proteins","volume":"14","author":"Skaar","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-009-0560-x","article-title":"The ubiquitin proteasome system in neuropathology","volume":"118","author":"Lehman","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(00)80574-7","article-title":"A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly","volume":"96","author":"Koegl","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80384","article-title":"The ubiquitin system","volume":"6","author":"Hershko","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2009.01.012","article-title":"A critical evaluation of the ubiquitin-proteasome system in Parkinson\u2019s disease","volume":"1792","author":"Cook","year":"2009","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-016-0218-2","article-title":"Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson\u2019s disease (PD)","volume":"9","author":"Zhou","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0165","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1038\/sj.emboj.7600775","article-title":"Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D\/cdk6","volume":"24","author":"Laman","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1107\/S1399004713025820","article-title":"Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interaction","volume":"70","author":"Shang","year":"2014","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0175","article-title":"Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15)","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/NEN.0b013e318293c586","article-title":"FBXO7 immunoreactivity in [alpha]-synuclein-containing inclusions in Parkinson disease and multiple system atrophy","volume":"72","author":"Zhao","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3700","article-title":"Roles of F-box proteins in cancer","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021165","article-title":"Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis","volume":"6","author":"Lomonosov","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0195","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1242\/jcs.080465","article-title":"Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells","volume":"124","author":"Meziane","year":"2011","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/cc.5.3.2403","article-title":"Fbxo7 gets proactive with cyclin D\/cdk6","volume":"5","author":"Laman","year":"2006","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0205","doi-asserted-by":"crossref","first-page":"32592","DOI":"10.1074\/jbc.M404950200","article-title":"Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region","volume":"279","author":"Hsu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.200511132","article-title":"HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture","volume":"173","author":"Wong","year":"2006","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0215","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbrc.2006.02.061","article-title":"The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination","volume":"342","author":"Chang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0220","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1093\/hmg\/ddv340","article-title":"F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha -synuclein by parkin from human brain: implications for Parkinson\u2019s disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science (80-)"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2011.03.021","article-title":"A conserved F box regulatory complex controls proteasome activity in Drosophila","volume":"145","author":"Bader","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0235","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.15252\/embj.201593585","article-title":"Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice","volume":"35","author":"Vingill","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuron.2005.07.008","article-title":"Ubiquitin and protein turnover in synapse function","volume":"47","author":"Yi","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0245","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1042\/BCJ20160387","article-title":"Gsk3\u03b2 and Tomm20 are substrates of the SCFFbxo7\/PARK15 ubiquitin ligase associated with Parkinson\u2019s disease","volume":"473","author":"Teixeira","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0250","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1073\/pnas.1506593112","article-title":"Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy","volume":"112","author":"Ordureau","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0255","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/35096075","article-title":"The renaissance of GSK3","volume":"2","author":"Cohen","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027686","article-title":"GSK3\u03b2 is involved in the relief of mitochondria pausing in a Tau-dependent manner","volume":"6","author":"Llorens-Mart\u00edn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0146726","article-title":"FOXO1 and GSK-3\u03b2 are main targets of insulin-mediated myogenesis in C2C12 muscle cells","volume":"11","author":"Litwiniuk","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0270","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11302-016-9548-x","article-title":"Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver","volume":"13","author":"Duarte","year":"2017","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-010-6234-z","article-title":"Mitochondria and GSK-3\u03b2 in cardioprotection against ischemia\/reperfusion injury","volume":"24","author":"Miura","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2008.10.104","article-title":"Glycogen synthase kinase-3beta is associated with Parkinson\u2019s disease","volume":"449","author":"Nagao","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0290","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2010.09.059","article-title":"Mitochondrial translation initiation factor 3 polymorphism and Parkinson\u2019s disease","volume":"486","author":"Behrouz","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0295","first-page":"217","article-title":"CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease","volume":"38","author":"he","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.parkreldis.2017.02.025","article-title":"Parkinsonian-pyramidal syndromes: a systematic review","volume":"39","author":"Tranchant","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0305","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a Parkinsonian-Pyramidal syndrome pedigree by 500 K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0310","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.parkreldis.2014.07.016","article-title":"FBXO7-R498X mutation: Phenotypic variability from chorea to early onset parkinsonism within a family","volume":"20","author":"G\u00fcnd\u00fcz","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0315","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.parkreldis.2014.06.024","article-title":"A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism","volume":"20","author":"Yalcin-Cakmakli","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0320","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.26266","article-title":"A new F-box protein 7 gene mutation causing typical Parkinson\u2019s disease","volume":"30","author":"Lohmann","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2017.11.332","article-title":"Juvenile-onset parkinsonism with pyramidal signs due to compound heterozygous mutations in the F-Box only protein 7 gene","volume":"47","author":"Wei","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0330","first-page":"20","article-title":"F-Box only protein 7 gene in Parkinsonian-Pyramidal disease","volume":"70","author":"Deng","year":"2013","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0335","doi-asserted-by":"crossref","first-page":"19804","DOI":"10.1074\/jbc.M111.220079","article-title":"A competitive binding mechanism between Skp1 and exportin 1 (CRM1) controls the localization of a subset of F-box proteins","volume":"286","author":"Nelson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0340","first-page":"2675","article-title":"The missing puzzle piece: Splicing mutations","volume":"6","author":"Lewandowska","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0345","first-page":"192","article-title":"FBXO7 mutations in Parkinson\u2019s disease and multiple system atrophy","volume":"40","author":"Conedera","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0350","first-page":"727","article-title":"Systematic mutational analysis of FBXO7 in a Parkinson\u2019s disease population from southern Spain","volume":"35","author":"G\u00f3mez-Garre","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0355","article-title":"FBXO7 Y52C polymorphism as a potential protective factor in Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0360","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.neurobiolaging.2012.12.023","article-title":"Mutational analysis of FBXO7 gene in Parkinson\u2019s disease in a Taiwanese population","volume":"34","author":"Lin","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10048-010-0259-0","article-title":"Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability","volume":"12","author":"Santoro","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0370","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/MCB.00079-08","article-title":"Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation","volume":"28","author":"Shao","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0375","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1038\/sj.emboj.7601874","article-title":"Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena\/VASP","volume":"26","author":"Ferron","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1605964113","article-title":"Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0385","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nn.3489","article-title":"The Parkinson\u2019s disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy","volume":"16","author":"Burchell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0390","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fgene.2012.00297","article-title":"Mitophagy in neurodegeneration and aging","volume":"3","author":"Palikaras","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0395","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4161\/auto.24135","article-title":"After the banquet: mitochondrial biogenesis, mitophagy, and cell survival","volume":"9","author":"Zhu","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.mrrev.2018.10.001_bib0400","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","article-title":"Parkin and PINK1: much more than mitophagy","volume":"37","author":"Scarffe","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0405","first-page":"439","article-title":"Potential pathophysiological crosstalk between Parkin and FBXO7 signalling pathways","volume":"12","author":"Zhou","year":"2016","journal-title":"Electronical J. Biol."},{"key":"10.1016\/j.mrrev.2018.10.001_bib0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cdd.2016.104","article-title":"Deficiency of Parkinson\u2019s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation","volume":"24","author":"Delgado-Camprubi","year":"2017","journal-title":"Cell Death Differ."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357421830067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357421830067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:19:23Z","timestamp":1761301163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138357421830067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":82,"alternative-id":["S138357421830067X"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2018.10.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson\u2019s disease (PD)","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}